In 2024, a wave of new CPT® code changes swept charge masters, delivered by the American Medical Association (AMA), officially effective at the start of the new year. With a vast multitude of coding changes, it’s necessary to review the coding throughout the first half of the year to understand and solidify the nuances that could create challenges at any time. The current codes, guidelines, and parenthetical changes can be found in the 2024 CPT Professional codebook. Due to the abundance of updates, only select changes will be highlighted below. Let’s explore some expert tips and insights on these individual codes.
| CPT code | CPT description | Revenue Code |
| 82166 | Anti-mullerian hormone (AMH) | 0300, 0301, 0309 |
The newly introduced code enables the quantitative assessment of AMH levels in serum.
Newly included in the 2024 AMA CPT Manual, the following chemistry-related PLA code for neurofilament light chain (NfL) analysis was added to CPT, having become effective on January 1, 2023, but first appearing in the 2024 AMA CPT Manual as a new code.
| CPT code | CPT description | Revenue Code |
| 0361U | Neurofilament light chain, digital immunoassay, plasma, quantitative | 0300, 0301, 0309 |
Code 0361U is for assessing neuronal damage related to various neurodegenerative diseases.
For additional details on the PLA code set including proprietary name and clinical laboratory or manufacturer, refer to Appendix O of the AMA CPT Manual. For the latest updates, go to https://www.ama-assn.org/practice-management/cpt/cpt-pla-codes.
In 2024, new CPT codes were introduced in Microbiology. Notably, PLA code 0408U for COVID-19 infectious agent detection via bulk acoustic wave biosensor immunoassay made its debut in the 2024 AMA CPT Manual, with an effective date of October 1, 2023.
For comprehensive information regarding the conclusion of the COVID-19 public health emergency (PHE), please refer to Chapter 18. For detailed insights into the PLA code set, including the most recent additions pertaining to microbiology, consult Appendix O of the CPT Manual. For up-to-date information on PLA code updates, visit https://www.ama-assn.org/practice-management/cpt/cpt-pla-codes.
| CPT code | CPT description | Revenue Code |
| 87523 | Infectious agent detection by nucleic acid (DNA or RNA); hepatitis D (delta), quantification, including reverse transcription, when performed | 0300, 0306, 0309 |
| 87593 | Infectious agent detection by nucleic acid (DNA or RNA); Orthopoxvirus (eg, monkeypox virus, cowpox virus, vaccinia virus), amplified probe technique, each | 0300, 0306, 0309 |
First introduced in 2022 to detect the Orthopoxvirus as a response to the monkeypox outbreak in the United States, CPT code 87593 is now making its debut in the 2024 edition of the CPT manual. Additionally, the following PLA codes, which were added for reporting microbiology-related services, first appeared in the 2024 AMA CPT Manual, but became effective in 2023:
| CPT code | CPT description | Revenue Code |
| 0369U | Infectious agent detection by nucleic acid (DNA and RNA), gastrointestinal pathogens, 31 bacterial, viral, and parasitic organisms and identification of 21 associated antibiotic-resistance genes, multiplex amplified probe technique | 0300, 0306, 0309 |
| 0370U | Infectious agent detection by nucleic acid (DNA and RNA), surgical wound pathogens, 34 microorganisms and identification of 21 associated antibiotic-resistance genes, multiplex amplified probe technique, wound swab | 0300, 0306, 0309 |
| 0371U | Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogen, semiquantitative identification, DNA from 16 bacterial organisms and 1 fungal organism, multiplex amplified probe technique via quantitative polymerase chain reaction (qPCR), urine | 0300, 0306, 0309 |
| 0373U | Infectious agent detection by nucleic acid (DNA and RNA), respiratory tract infection, 17 bacteria, 8 fungus, 13 virus, and 16 antibiotic-resistance genes, multiplex amplified probe technique, upper or lower respiratory specimen | 0300, 0306, 0309 |
| 0374U | Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogens, identification of 21 bacterial and fungal organisms and identification of 21 associated antibiotic-resistance genes, multiplex amplified probe technique, urine | 0300, 0306, 0309 |
| 0402U | Infectious agent (sexually transmitted infection), Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, multiplex amplified probe technique, vaginal, endocervical, or male urine, each pathogen reported as detected or not detected | 0300, 0306, 0309 |
| 0416U | Infectious agent detection by nucleic acid (DNA), genitourinary pathogens, identification of 20 bacterial and fungal organisms, including identification of 20 associated antibiotic-resistance genes, if performed, multiplex amplified probe technique, urine | 0300, 0306, 0309 |
The following PLA code was deleted effective October 1, 2023, and referenced as such in the AMA CPT Manual for 2024:
| CPT code | CPT description | Revenue Code |
| 0066U | Placental alpha-micro globulin-1 (PAMG-1), immunoassay with direct optical observation, cervicovaginal fluid, each specimen | 0300, 0306, 0309 |
For qualitative evaluation of cervicovaginal fluid for specific amniotic fluid proteins such as PAMG-1, refer to existing CPT code 84112.
Lab Week has arrived offering a time dedicated to honoring and celebrating the invaluable contributions of medical lab professionals and pathologists. As an expression of gratitude for your unwavering commitment to healthcare excellence, we have an exclusive limited- time offer.
From April 16th to April 26th, you can enjoy a generous 20% discount on our Laboratory All Access Pass using the code LABWEEK24. Whether you’re a newcomer or a longtime supporter, this offer is our way of saying thank you for being part of our community. Don’t miss out on this chance to unlock unparalleled access to our lab resources at an unbeatable price!*
In a recent article, I described a documentation environment governed by two distinct and often competing controlling systems. The first is the regulatory framework established
Coders may very well feel that they have no impact on hospitals under H.R.1, the so-called One Big Beautiful Bill Act (OBBBA). Just the opposite
Please log in to your account to comment on this article.
Sepsis sequencing continues to challenge even experienced coding and CDI professionals, with evolving guidelines, documentation gaps, and payer scrutiny driving denials and data inconsistencies. In this webcast, Payal Sinha, MBA, RHIA, CCDS, CDIP, CCS, CCS-P, CCDS-O, CRC, CRCR, provides clear guideline-based strategies to accurately code sepsis, severe sepsis, and septic shock, assign POA indicators, clarify the relationship between infection and organ dysfunction, and align documentation across teams. Attendees will gain practical tools to strengthen audit defensibility, improve first-pass accuracy, support appeal success, reduce denials, and ensure accurate quality reporting, empowering organizations to achieve consistent, compliant sepsis coding outcomes.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
